Anti-His tag antibody

Thymosin beta 10 (TB10) is one of the common members among beta-thymosins. Human TB10 is reported to play a role in anti-angiogenesis and inhibition of cell migration during the tumorigenesis or metastasis of some certain cancers. Thus, it would be a potent clinical agent. In the present study, the coding sequence of TB10 was optimized based on the codon preference of Escherichia coli and cloned to pET28a (+) by chemical synthesis and molecular cloning methods. The recombinant protein was highly expressed employing E. coli expressing system and purified by a simple step of Ni2+ affinity chromatography. The TEV proteinase recognition site was inserted in the His(6)-tag and the target protein for easy removal of the His(6)-tag. To improve the biological activity of TB10, the transactivator of transcription (TAT) short peptide, a transduction domain, was added to the N-terminus of TB10. About 14.3 mg of the recombinant TB10 proteins was obtained from 1 L bacterial culture. The functional analyses demonstrated that the recombinant TB10 proteins displayed the distinct inhibition on angiogenesis by chick embryo chorioallantoic membrane assay and endothelial cell migration by wound healing assay. The TAT-fused TB10 even had stronger effects, probably due to the better transduction into the cells.

The 22 kDa of human growth hormone (hGH) is naturally produced and secreted by somatotrophic cells in the anterior part of the pituitary gland. The aim of this study was to clone, express, purify of hGH as fusion to the pelB leader in pET22b (+) plasmid and evaluate it's biological properties. The hGH polypeptide codon was optimized and subcloned. The recombinant hGH protein was purified by affinity chromatographic system against His-tag and the presence and accuracy of the purified products were evaluated by protein electrophoresis and Western blot. The biological activity of recombinant hGH protein was measured using ELISA assay. The results of sequencing of hGH gene confirmed the presence and proper placement of hGH gene and it's subcloning in the plasmid pET22b (+). The results of the protein electrophoresis and Western blot assays demonstrated that the expression accuracy of 22 kDa recombinant hGH. The results of Bradford spectroscopy assay showed that the recombinant hGH protein concentration was 1 g/l. The results of classical sandwich ELISA assay, in contrast to the specific antibodies, confirmed the bio-activity of the recombinant hGH protein in its targeting. Consequently, the results of this study showed that pelB leader has the ability to more accurately direct hGH to periplasmic space in Escherichia coli, and the conditions of oxidizing periplasmic space give rise to the correct folding of the protein in this space. Furthermore, the results of current study proved that using bioinformatics tools and combining them with laboratory data, could improve the recombinant hGH expression in E. coli, in addition to preserving bio-activity.